Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

141.11
Delayed Data
As of Feb 12
 +5.75 / +4.25%
Today’s Change
130.51
Today|||52-Week Range
208.88
-26.02%
Year-to-Date

Today’s Trading

Previous close135.36
Today’s open136.91
Day’s range134.31 - 141.26
Volume1,595,206
Average volume (3 months)1,635,981
Market cap$31.8B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+4.36%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+12.25%
P/E ratio211.0
Price/Sales16.57
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
SHPGShire+8.90+5.89%
VRXValeant Pharmaceutic...+4.95+5.93%
MYLMylan NV+0.41+0.98%
VRTXVertex Pharmaceutica...+3.52+4.42%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.13
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts

Partner Offers